PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | |infection |
| Sentences | 498 |
| PubMedID- 20140950 | Little is known about hepatitis b virus (hbv) infection among patients with chronic hepatitis c virus (hcv) infection in the united states. |
| PubMedID- 22878070 | The aim of this report is to evaluate whether pregnancy is a risk factor for poor outcome of infection with hepatitis c virus or for allograft deterioration among kidney transplant recipients. |
| PubMedID- 22921476 | Baseline infection with hepatitis c or b was the only significant predictor of moving from low to elevated transaminase levels; 9 bup and 15 met participants showed extreme liver test elevations and were more likely than those without extreme elevations to have seroconverted to both hepatitis b and c during the study, or to use illicit drugs during the first 8 weeks of treatment. |
| PubMedID- 23499158 | Background: protease inhibitors have improved treatment of infection with hepatitis c virus (hcv), but dosing, a low barrier to resistance, drug interactions, and side-effects restrict their use. |
| PubMedID- 26308395 | Carriers of the deltag allele have impaired ability to clear infection with hepatitis c virus (hcv). |
| PubMedID- 20513077 | Case report: cure of chronic infection with hepatitis c virus after 6 weeks of peg-interferon and ribavirin in a patient co-infected with hiv. |
| PubMedID- 24013001 | infection with genotype 3 hepatitis c virus (hcv) is common throughout the world, however no direct-acting antiviral (daa) has been approved to treat this genotype. |
| PubMedID- 24251062 | Significant comorbidities include infection with hepatitis c virus (grade 1, stage 0). |
| PubMedID- 23933401 | Background and aims: infection with the hepatitis c virus (hvc) is one of the most common viral infections worldwide. |
| PubMedID- 24799891 | infection with hepatitis c virus (hcv) is a global health problem and it infects at least 170 million people worldwide with an estimated prevalence of 3 to 4 million newly acquired infections per year 1. |
| PubMedID- 24147097 | Concurrent infection with hepatitis c virus (hcv) and hepatitis b virus (hbv) was not uncommon in china. |
| PubMedID- 21716792 | It is worth noting that in patients presenting with anogenital wart, other associated stis were hiv, syphilis, hsv-2, hepatitis b, and hepatitis c. in patients with hpv–hiv co-infection, the warts were multiple, diffuse, and larger in size. |
| PubMedID- 21327958 | infection with hepatitis c virus (hcv) is a public health problem; it establishes a chronic course in ~85% of infected patients and increases their risk for developing liver cirrhosis, hepatocellular carcinoma, and significant extrahepatic manifestations. |
| PubMedID- 22863785 | T cell immunoglobulin and mucin domain-containing 3 (tim-3) is an inhibitory receptor that is expressed on exhausted t cells during infection with hiv-1 and hepatitis c virus. |
| PubMedID- 22158321 | In addition to these associations, there is substantial evidence for a causativerelationship between chronic infection with hepatitis c virus (hcv) and non-hodgkinlymphoma (nhl), an association that has been the subject of several recentsystematic reviews (gisbert et al, 2003;matsuo et al, 2004; dal maso and franceschi, 2006). |
| PubMedID- 25572289 | Persistent infection with hepatitis c virus (hcv) is a major risk factor in the development of hepatocellular carcinoma. |
| PubMedID- 21326840 | Chronic infection with hepatitis c virus is estimated to affect almost 4 million people in the usa, 5 million in europe, and 170 million worldwide 1. |
| PubMedID- 25767389 | infection with hepatitis c virus (hcv) is highly prevalent in chronic kidney disease (ckd) patients, mainly in those on hemodialysis (hd). |
| PubMedID- 25232427 | Background: hepatitis secondary to infection with the hepatitis c virus (hcv) is one of themost common causes of viral hepatitis worldwide. |
| PubMedID- 26048049 | Determinants of polyneuropathy were urban residence (p=0.02), infection with hepatitis c virus (p=0.002), infection with hiv (p=0.012) and presence of albuminuria (p=0.0001). |
| PubMedID- 23108300 | Persistent infection with the hepatitis c virus (hcv) is a major global health problem. |
| PubMedID- 22984515 | Overwhelming lines of epidemiological evidence have indicated that persistent infection with hepatitis c virus (hcv) is a major risk for the development of hepatocellular carcinoma (hcc). |
| PubMedID- 21068134 | Background and aims: a number of recent studies have shown that human polymorphisms near the il28b type iii interferon (ifnlambda) gene influence the response to peg-interferon plus ribavirin combination therapy for infection with chronic hepatitis c virus (hcv). |
| PubMedID- 23528526 | It has been suggested that infection with hepatitis c virus may inhibit hepatitis b virus replication. |
| PubMedID- 24168254 | From 2002 to 2011, the standard of care treatment for chronic infection with hepatitis c virus (hcv) was 24 or 48 weeks of therapy with pegylated interferon-alfa (peg-ifn) and ribavirin (rbv). |
| PubMedID- 21183794 | Chronic infection with hepatitis c virus (hcv) is a major public health problem, with nearly 170 million infected individuals worldwide. |
| PubMedID- 22533731 | Background: co-infection with hepatitis c (hcv) is very common in human immunodeficiency virus 1 (hiv-1) infected patients. |
| PubMedID- 19950239 | Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response. |
| PubMedID- 22022264 | infection of hepatocytes with hepatitis c virus (hcv) results in poor production of ifn despite recognition of the viral rna by rig-i but can lead to induction of early isgs. |
| PubMedID- 25198705 | Chronic infection with hepatitis c virus (hcv) is associated with a large spectrum of extrahepatic manifestations (ehms), mostly immunologic/rheumatologic in nature owing to b-cell proliferation and clonal expansion. |
| PubMedID- 22347865 | Acute hav super infection in carriers of chronic hepatitis c has been associated with a particularly high mortality rate, dozens of times higher than hav infection in the gpop (who, 2000; keeffe, 2006; kumar and herrera, 2010). |
| PubMedID- 24422784 | infection with hepatitis c virus (hcv) is the most common cause of end-stage liver disease and the most frequent reason for liver transplantation in the united states 1. |
| PubMedID- 21994698 | infection with hepatitis c virus (hcv) continues to be a major global health problem. |
| PubMedID- 25111807 | infection with the hepatitis c virus (hcv) is a major cause of chronic liver diseases and hepatocellular carcinoma worldwide, and thus represents a significant public health problem. |
| PubMedID- 26035647 | Chronic infection with hepatitis c virus (hcv) is characterized by liver fibrosis and cirrhosis, metabolic disorders (steatosis, insulin resistance, iron overload) and liver cancer . |
| PubMedID- 20332260 | Background: chronic infection with hepatitis c virus (hcv) confers increased risk for chronic renal disease, and numerous reports suggest an association with renal cell carcinoma (rcc), a cancer with rapidly rising global incidence. |
| PubMedID- 22899946 | Chronic infection with hepatitis c virus (hcv) is associated with a wide spectrum of extrahepatic manifestations, affecting different organ systems. |
| PubMedID- 25476473 | During the interview reported treatment of chronic infection with hepatitis c virus (hcv) with peginterferon and ribavirin. |
| PubMedID- 20622998 | A clear aggregated environmental risk factor for the development of cirrhosis attributable to alcohol consumption is infection with hepatitis c virus (hcv). |
| PubMedID- 21394322 | Since the introduction of highly active antiretroviral therapy (haart) in 1996 for human immunodeficiency virus (hiv)-infected patients, the incidence of liver diseases secondary to co-infection with hepatitis c has increased. |
| PubMedID- 25979354 | infection of hepatocytes with hepatitis c virus led to the incorporation and export of viral genomic and sub-genomic rna sequences in evs. |
| PubMedID- 24175062 | Chronic infection with hepatitis c virus (hcv) is treated with a combined therapy of peginterferon-α-2a (pegifn-α-2a) or pegifn-α-2b and ribavirin. |
| PubMedID- 23136221 | Background: infection with hepatitis c virus (hcv) is a burgeoning worldwide public health problem, with 170 million infected individuals and an estimated 20 million deaths in the coming decades. |
| PubMedID- 22741810 | Hiv co-infection worsens the course of viral hepatitis causing faster progression of fibrosis and earlier development of cirrhosis. |
| PubMedID- 24767674 | Egypt, with nearly 90 million habitants, has the highest infection rate of hepatitis c worldwide, with a prevalence of 10% according to the official records of the egyptian ministry of health and population (5). |
| PubMedID- 23667408 | We and others have previously shown that infection with hepatitis c virus (hcv) or expression of the viral proteins can trigger the upr. |
| PubMedID- 22848445 | Chronic infection with the hepatitis c virus (hcv) affects an estimated 2–3% of the world's population and is a leading cause of cirrhosis and hepatocellular carcinoma 1. |
| PubMedID- 20163377 | Background: chronic infection with hepatitis c, genotype 2/3, responds better than other genotypes to peginterferon and ribavirin treatment. |
| PubMedID- 21415945 | infection with hepatitis c virus (hcv) is an increasing epidemic with over 180 million people infected worldwide. |
| PubMedID- 22129112 | Co-infection with hepatitis c occurred in more than 10% of cases, which can also enhance transmission of hiv . |